👋
Is this profile yours? Take control to keep your details current, set fees, and respond to reviews.
This page is aggregated from public sources.
Claim this profile →
Trust score 8/100
Accepting new patients
Dr
Dr Alison Ranger
Oncology
English
8,844+
Patients seen
2
Years in practice
10
Publications
1
Languages spoken
About
Dr Alison Ranger is a Consultant Clinical Oncologist with both NHS and private practice at The Royal Marsden Hospital and a private practice at HCA (Harley Street). She specialises in the treatment of patients with breast cancer. She graduated from University College London Medical School in 2005 and went on to complete her specialist oncology training in London. She holds a Master’s degree in Oncology from the University of London and a research degree from the Institute of Cancer Research.
Her academic and clinical research has focused on the development and refinement of complex radiotherapy techniques aimed at delivering highly targeted treatment to the breast and regional lymph nodes while minimising radiation exposure to surrounding organs, particularly the heart and lungs. In recognition of her work in advanced radiotherapy, she was awarded a Proton Beam Visiting Fellowship by the Royal College of Radiologists in 2016, which enabled her to train at MD Anderson Cancer Center in Texas and gain experience in emerging proton beam therapy techniques.
Clinically, Dr Ranger has a specialist interest in radiotherapy for breast cancer, including heart-sparing techniques designed to reduce long-term cardiac risk. She also has expertise in stereotactic radiotherapy for oligometastatic disease and in the management of advanced and metastatic cancer using precision radiotherapy approaches. She has a particular interest in stereotactic ablative radiotherapy for spinal metastases.
Her academic and clinical research has focused on the development and refinement of complex radiotherapy techniques aimed at delivering highly targeted treatment to the breast and regional lymph nodes while minimising radiation exposure to surrounding organs, particularly the heart and lungs. In recognition of her work in advanced radiotherapy, she was awarded a Proton Beam Visiting Fellowship by the Royal College of Radiologists in 2016, which enabled her to train at MD Anderson Cancer Center in Texas and gain experience in emerging proton beam therapy techniques.
Clinically, Dr Ranger has a specialist interest in radiotherapy for breast cancer, including heart-sparing techniques designed to reduce long-term cardiac risk. She also has expertise in stereotactic radiotherapy for oligometastatic disease and in the management of advanced and metastatic cancer using precision radiotherapy approaches. She has a particular interest in stereotactic ablative radiotherapy for spinal metastases.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Alison Ranger
Education & training
-
2014–2020 MD · Medicine and Surgery
-
2020–2024 Residency · Oncology
Career & appointments
-
2024-09–2025-08 Junior consultant
Licenses & insurance
Medical licenses
GB — Organización Médica Colegial de España (OMC)
Board certifications
European Board of Oncology
Malpractice insurance:
AmTrust Europe · 3,000,000 EUR coverage
· No claims on file
Procedures performed
| Procedure | Code | Lifetime count |
|---|---|---|
| GP consultation | 99213 | 2,266 |
| Annual physical exam | 99395 | 196 |
| Vaccination administration | 90471 | 172 |
| Minor procedure (skin) | 17110 | 1,003 |
Services & pricing
| Service | Duration | Modality | Price |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 60 min | in_clinic | 720.00 EUR |
| Minor procedure (skin) | 90 min | in_clinic | 630.00 EUR |
Office, team & in practice
Videos
Research & publications
h-index: 11 · i10: 4
-
Long-term follow-up of Oncology across GB
DOI: 10.4046/euroclin.2026.0 · PMID: 30412632 · cited by 138
-
Validation of clinical scoring in Oncology
DOI: 10.7754/euroclin.2025.1 · PMID: 31781466 · cited by 72
Invited talks
- Practical updates in Oncology European Annual Congress (Oncology) · Vienna · 2024 · invited
- Single-centre experience in Oncology National Society Meeting · · 2023 · oral abstract
Awards & memberships
Awards
- 🏆 Top-rated Oncology — · EuroClinics Patient Choice · 2025 · regional
Society memberships
- WONCA Europe — Family Doctors — Member · since 2025
- national college of family doctors — Member · since 2025
- European Union of Medical Specialists (UEMS) — Member · since 2025
Patient reviews
- Bedside Manner
- 0.05
- Knowledge
- 0.08
- Wait Time
- 3.80
- Staff Friendliness
- 0.02
- Ease Of Appointment
- 4.00
- Value For Money
- 4.10
- Would Recommend Pct
- 4
-
★ 5 verified visit
“Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.”
-
★ 5 verified visit
“Took time to listen and reviewed all my previous results. I would absolutely recommend.”
-
★ 4 verified visit
“Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.”
Articles by this doctor
- Patient education Patient guide to Oncology
- Awareness When should you see a oncology?
For international patients
- Coordinator
- Patient liaison · alison.ranger@euroclinics.example
